Clinical Trials Logo

Type II Non-Obese Diabetic clinical trials

View clinical trials related to Type II Non-Obese Diabetic.

Filter by:
  • None
  • Page 1

NCT ID: NCT02332993 Completed - Wound Clinical Trials

Nutritional Regulation of Wound Inflammation: Part III

FPP3
Start date: December 2014
Phase:
Study type: Observational

The purpose of this study is to examine the changes that result in the wound healing of a type II Diabetic using Negative Pressure Therapy after 12 weeks of daily supplementation of ImmunAge (Fermented Papaya Preparation (FPP). ImmunAge (FPP) is a supplement made from Carica papaya Linn and is available over the counter. ImmunAge (FPP) is an investigational drug, which means it has not been approved by the U. S. Food and Drug Administration (FDA). Approximately 30 subjects will participate in this study. 15 subjects will take the supplementation and 15 subjects to take no supplementation as the control. The